Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Posterior Wall Substrate Modification Using Irreversible Electroporation for the Treatment of Paroxysmal Atrial Fibrillation

NCT06364215 is registered in ClinicalTrials.gov with Jorge Romero as lead sponsor.

NCT NCT06364215
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06364215 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Posterior Wall Substrate Modification Using Irreversible Electroporation for the Treatment of Paroxysmal Atrial Fibrillation
Lead sponsor
Jorge Romero
Phase
Not applicable
Overall status
Terminated
Start date
October 8, 2024
Completion date
November 16, 2025
Enrollment
198 (actual)
Sites
18

Conditions

As the registry lists them; a condition with its own page is linked.

atrial fibrillation paroxysmal